To display how Finland and Finnish solutions participate in the fight against cancer, Business Finland has compiled a new digital booklet, providing an overview of the extensive know-how and current areas of innovation. Biovian’s CDMO …
A conversation with Pirjo Merilahti, PhD., Virology. At Biovian, Viral Vector process development is planned and executed by a team of experienced scientists, led by Dr Pirjo Merilahti. Her team typically starts the project with …
Take Advantage of One-on-One Partnering! Schedule a virtual meeting with Magnus Gustafsson, the Head of Global Business Development of Biovian and find out how we can help your gene therapy or biopharma project from the …
The therapeutic possibilities of cell and gene therapy are very appealing. The possibility to use a Viral Vector to carry the therapeutic gene into the target cells or to initiate cell transduction holds the potential …